These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26899479)

  • 21. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
    Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR; Patel DB; Schein AJ; White EA; Menendez LR
    Skeletal Radiol; 2015 Jul; 44(7):1027-31. PubMed ID: 25712768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteosclerosis induced by denosumab.
    Kobayashi E; Setsu N
    Lancet; 2015 Feb; 385(9967):539. PubMed ID: 25465110
    [No Abstract]   [Full Text] [Related]  

  • 25. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
    Thomas D; Henshaw R; Skubitz K; Chawla S; Staddon A; Blay JY; Roudier M; Smith J; Ye Z; Sohn W; Dansey R; Jun S
    Lancet Oncol; 2010 Mar; 11(3):275-80. PubMed ID: 20149736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Giant cell tumor of bone under Denosumab treatment.
    Wendling D; Guillot X; Sondag M; Chaigneau L; Aubry S; Prati C
    Joint Bone Spine; 2018 Jul; 85(4):491. PubMed ID: 28970075
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
    Lau CP; Huang L; Wong KC; Kumta SM
    Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
    Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report.
    van der Heijden L; van de Sande MA; Hogendoorn PC; Gelderblom H; Dijkstra PD
    Acta Orthop; 2015 Jun; 86(3):393-5. PubMed ID: 25684041
    [No Abstract]   [Full Text] [Related]  

  • 30. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
    Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant cell tumour of bone in the denosumab era.
    van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
    Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How safe and effective is denosumab for bone giant cell tumour?
    Errani C; Tsukamoto S; Mavrogenis AF
    Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D; A Taguibao R; A Strle N; E Burns J
    Skeletal Radiol; 2017 Apr; 46(4):571-578. PubMed ID: 28188337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone.
    Engellau J; Seeger L; Grimer R; Henshaw R; Gelderblom H; Choy E; Chawla S; Reichardt P; O'Neal M; Feng A; Jacobs I; Roberts ZJ; Braun A; Bach BA
    World J Surg Oncol; 2018 Sep; 16(1):191. PubMed ID: 30231890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
    Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
    Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
    Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
    Mukaihara K; Suehara Y; Kohsaka S; Akaike K; Tanabe Y; Kubota D; Ishii M; Fujimura T; Kazuno S; Okubo T; Takagi T; Yao T; Kaneko K; Saito T
    PLoS One; 2016; 11(2):e0148401. PubMed ID: 26863138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
    J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.